← Back to Search

Functional MRI for Brain Tumor Surgery Assessment

Q: Am I eligible to join this trial?

<p>30 people with <a href="https://www.withpower.com/clinical-trials/glioma">glioma</a>, aged between 18 and 75 are invited to take part in this research. To be eligible for enrollment, subjects must also meet a strict set of criteria such as being right-handed and not having prior neurological issues or psychiatric complications which could alter cognitive abilities. It is required that participants undergo neurosurgical intervention along with the corresponding pre-operative and post-operative neuropsychological assessments per standard medical procedure.</p>

N/A

Recruiting

Led By Ho-Ling A Liu

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 weeks

Awards & highlights

Study Summary

This trial looks at how well two types of MRI work in measuring language function before and after surgery for brain tumors.

Who is the study for?

This trial is for right-handed English speakers with a new brain mass suspected to be glioma, located near critical language areas. They must not have had prior neurologic diseases or treatments affecting cognition and should agree to pre- and post-surgery neuropsychological tests.Check my eligibility

What is being tested?

The study measures the impact of surgery on language functions in glioma patients using resting-state functional MRI and cerebrovascular reactivity MRI before and after their operations.See study design

What are the potential side effects?

Since this trial involves non-invasive imaging techniques like MRI, side effects are minimal but may include discomfort from lying still during the scan or noise from the machine.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Detectability of language networks

Secondary outcome measures

Changes in resting-state functional connectivity and neuropsychological outcomes

Trial Design

1Treatment groups

Experimental Treatment

Group I: Diagnostic (fMRI, CVR MRI, rs-fMRI)Experimental Treatment3 Interventions

Patients undergo standard of care fMRI, CVR MRI over 3 minutes, and rs-fMRI over 6 minutes 1 month before and within 6 weeks after standard of care surgery.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Functional Magnetic Resonance Imaging

2016

Completed Phase 4

~890

Magnetic Resonance Imaging

2017

Completed Phase 3

~1190

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,789,444 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,411 Total Patients Enrolled

Ho-Ling A LiuPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Functional Magnetic Resonance Imaging Clinical Trial Eligibility Overview. Trial Name: NCT03964909 — N/A

Brain Tumor Research Study Groups: Diagnostic (fMRI, CVR MRI, rs-fMRI)

Brain Tumor Clinical Trial 2023: Functional Magnetic Resonance Imaging Highlights & Side Effects. Trial Name: NCT03964909 — N/A

Functional Magnetic Resonance Imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT03964909 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study open to individuals aged 35 and older?

"As laid out in the eligibility requirements, the lower limit for participation is 18 years old and individuals must be 75 or younger."

Answered by AI

Am I eligible to join this trial?

"30 people with glioma, aged between 18 and 75 are invited to take part in this research. To be eligible for enrollment, subjects must also meet a strict set of criteria such as being right-handed and not having prior neurological issues or psychiatric complications which could alter cognitive abilities. It is required that participants undergo neurosurgical intervention along with the corresponding pre-operative and post-operative neuropsychological assessments per standard medical procedure."

Answered by AI

Is the capacity of this clinical trial still accommodating new participants?

"According to the authoritative source, clinicaltrials.gov, this trial is still in its recruitment phase. The initial posting for this medical study was on April 24th 2017 and most recently updated on June 23rd 2022."

Answered by AI

How many individuals are being enrolled for this research endeavor?

"Absolutely. The clinicaltrials.gov database conveys that the trial, which was initially posted on April 24th 2017, is now actively looking for participants to join their study. 30 patients need to be found at a single medical centre in order for the research goals of this project to be met."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Resting-State Functional MRI in Glioma Patients Before and After Surgery

2017. "Resting-State Functional MRI in Glioma Patients Before and After Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03964909.

All > Glioma